Abeona Therapeutics Inc.
Abeona Therapeutics Inc. (ABEO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ABEO · as of Dec 31, 2024
Ownership Breakdown
1
Institutional Holders
▲ 1 vs Q3
$13,066
Total Inst. Value
▲ $13,066 vs Q3
57.00M
Shares Outstanding
freeFloat 63.77%
2,350
13F Shares Held
▲ 2,350 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ABEO largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
GAME PLAN FINANCIAL ADVISORS, LLC pharmaceutical preparations | 2.4K | 0.49% | 0.49% | $13.07M | Jan 30, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ABEO insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
4
Sell transactions
0.25
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Alvino Mark director | May 26, 2026 | Gift | 500 | — | — | 77.1K | Form 4 ↗ |
Alvino Mark director | May 22, 2026 | Sale | 6,500 | $5.46 | $35.5K | 77.6K | Form 4 ↗ |
Crombez Eric director | May 15, 2026 | Sale | 26,143 | $5.53 | $144.6K | 37.3K | Form 4 ↗ |
Vasanthavada Madhav Chief Commercial Officer | May 11, 2026 | Sale | 5,548 | $5.96 | $33.1K | 313.1K | Form 4 ↗ |
Goldan Keith A. director | Apr 1, 2026 | Award | 32,751 | — | — | 32.8K | Form 4 ↗ |
Seshadri Vishwas Chief Executive Officer | Mar 31, 2026 | Sale | 29,985 | $4.38 | $131.5K | 1.43M | Form 4 ↗ |
Vazzano Joseph Walter Chief Financial Officer | Mar 16, 2026 | Sale | 785 | $4.76 | $3.7K | 567.8K | Form 4 ↗ |
Silverstein Christine Berni director | Feb 2, 2026 | Sale | 20,070 | $5.09 | $102.2K | 137.7K | Form 4 ↗ |
Wuchterl Donald A. director | Feb 2, 2026 | Sale | 14,814 | $5.09 | $75.4K | 167.9K | Form 4 ↗ |
Crombez Eric director | Feb 2, 2026 | Sale | 16,284 | $5.09 | $82.9K | 63.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Abeona Therapeutics Inc. (ABEO) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 36.23%, while retail and public investors account for the remaining 63.76%.
The largest institutional shareholder of Abeona Therapeutics Inc. is GAME PLAN FINANCIAL ADVISORS, LLC, holding approximately 2,350 shares — equal to 0.49% of outstanding shares — as of December 31, 2024.
A total of 1 institutional investors currently hold ABEO stock, with a combined institutional value of approximately $13,066 as of the most recent 13F filing period.
Frequently asked questions
ABEO ownershipAbeona Therapeutics Inc. (ABEO) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is GAME PLAN FINANCIAL ADVISORS, LLC with a 0.49% stake. Company insiders hold 36.23%. Data sourced from SEC Form 13F as of December 31, 2024.